Oral ibrexafungerp outcomes in patients with chronic mucocutaneous candidiasis (CMC)

Category Primary study
JournalSwiss Medical Weekly
Year 2022
This article has no abstract
Epistemonikos ID: 0af92a317c95452ec0849cd466ac798b32ab51b6
First added on: Feb 15, 2025